spacer
spacer
Go to PDB code: 
protein links
Cytokine PDB id
2il6
Jmol
Contents
Protein chain
166 a.a. *
* Residue conservation analysis
PDB id:
2il6
Name: Cytokine
Title: Human interleukin-6, nmr, 32 structures
Structure: Interleukin-6. Chain: a. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
NMR struc: 32 models
Authors: G.Y.Xu,H.A.Yu,J.Hong,M.Stahl,T.Mcdonagh,L.E.Kay,D.A.Cumming
Key ref:
G.Y.Xu et al. (1997). Solution structure of recombinant human interleukin-6. J Mol Biol, 268, 468-481. PubMed id: 9159484 DOI: 10.1006/jmbi.1997.0933
Date:
31-Jan-97     Release date:   04-Feb-98    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P05231  (IL6_HUMAN) -  Interleukin-6
Seq:
Struc:
212 a.a.
166 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   1 term 
  Biological process     immune response   1 term 
  Biochemical function     cytokine activity     2 terms  

 

 
DOI no: 10.1006/jmbi.1997.0933 J Mol Biol 268:468-481 (1997)
PubMed id: 9159484  
 
 
Solution structure of recombinant human interleukin-6.
G.Y.Xu, H.A.Yu, J.Hong, M.Stahl, T.McDonagh, L.E.Kay, D.A.Cumming.
 
  ABSTRACT  
 
Interleukin-6 (IL-6) is a 185 amino acid cytokine which exerts multiple biological effects in vivo and whose dysregulation underlies several disease processes. The solution structure of recombinant human interleukin-6 has now been determined using heteronuclear three and four-dimensional NMR spectroscopy. The structure of the molecule was determined using 3044 distance and torsion restraints derived by NMR spectroscopy to generate an ensemble of 32 structures using a combined distance geometry/simulated annealing protocol. The protein contains five alpha-helices interspersed with variable-length loops; four of these helices constitute a classical four-helix bundle with the fifth helix located in the CD loop. There were no distance violations greater than 0.3 A in any of the final 32 structures and the ensemble has an average-to-the-mean backbone root-mean-square deviation of 0.50 A for the core four-helix bundle. Although the amino-terminal 19 amino acids are disordered in solution, the remainder of the molecule has a well defined structure that shares many features displayed by other long-chain four-helix bundle cytokines. The high-resolution NMR structure of hIL-6 is used to rationalize available mutagenesis data in terms of a heteromeric receptor complex.
 
  Selected figure(s)  
 
Figure 3.
Figure 3. Stereo image of the averaged and minimized NMR structure of IL-6. Only residues 20 to 185 are shown and individual helices are labeled.
Figure 4.
Figure 4. Best-fit superposition of the C^α atoms of the X-ray and the restrained minimized averaged NMR structures of IL-6. (a) The color coding scheme is identical to that of Figure 1. The average minimized NMR structure is shown in thick lines while the X-ray structure is shown in thin lines. (b) C^α-C^α distances after the best-fit superposition.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (1997, 268, 468-481) copyright 1997.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20100083 A.Sahoo, and S.H.Im (2010).
Interleukin and interleukin receptor diversity: role of alternative splicing.
  Int Rev Immunol, 29, 77.  
20303167 S.Yachamaneni, G.Yushin, S.H.Yeon, Y.Gogotsi, C.Howell, S.Sandeman, G.Phillips, and S.Mikhalovsky (2010).
Mesoporous carbide-derived carbon for cytokine removal from blood plasma.
  Biomaterials, 31, 4789-4794.  
16972794 O.Hecht, A.J.Dingley, A.Schwanter, S.Ozbek, S.Rose-John, and J.Grötzinger (2006).
The solution structure of the membrane-proximal cytokine receptor domain of the human interleukin-6 receptor.
  Biol Chem, 387, 1255-1259.
PDB code: 2arw
15565298 H.Hampel, A.Haslinger, M.Scheloske, F.Padberg, P.Fischer, J.Unger, S.J.Teipel, M.Neumann, C.Rosenberg, R.Oshida, C.Hulette, D.Pongratz, M.Ewers, H.A.Kretzschmar, and H.J.Möller (2005).
Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain.
  Eur Arch Psychiatry Clin Neurosci, 255, 269-278.  
14557255 A.Schwantner, A.J.Dingley, S.Ozbek, S.Rose-John, and J.Grötzinger (2004).
Direct determination of the interleukin-6 binding epitope of the interleukin-6 receptor by NMR spectroscopy.
  J Biol Chem, 279, 571-576.  
15573128 K.W.Lynch (2004).
Consequences of regulated pre-mRNA splicing in the immune system.
  Nat Rev Immunol, 4, 931-940.  
12715892 S.Bosze, F.Hudecz, P.Igaz, Z.Ortutay, G.Csík, A.Falus, and S.Tóth (2003).
Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells.
  Biol Chem, 384, 409-421.  
12692211 T.M.Rose, J.T.Ryan, E.R.Schultz, B.W.Raden, and C.C.Tsai (2003).
Analysis of 4.3 kilobases of divergent locus B of macaque retroperitoneal fibromatosis-associated herpesvirus reveals a close similarity in gene sequence and genome organization to Kaposi's sarcoma-associated herpesvirus.
  J Virol, 77, 5084-5097.  
11788581 C.Cebo, V.Durier, P.Lagant, E.Maes, D.Florea, T.Lefebvre, G.Strecker, G.Vergoten, and J.P.Zanetta (2002).
Function and molecular modeling of the interaction between human interleukin 6 and its HNK-1 oligosaccharide ligands.
  J Biol Chem, 277, 12246-12252.  
12461182 J.N.Varghese, R.L.Moritz, M.Z.Lou, A.Van Donkelaar, H.Ji, N.Ivancic, K.M.Branson, N.E.Hall, and R.J.Simpson (2002).
Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.
  Proc Natl Acad Sci U S A, 99, 15959-15964.
PDB codes: 1n26 1n2q
11816044 N.Yamada, E.Suzuki, and K.Hirayama (2002).
Identification of the interface of a large protein-protein complex using H/D exchange and Fourier transform ion cyclotron resonance mass spectrometry.
  Rapid Commun Mass Spectrom, 16, 293-299.  
12235153 T.Taverner, N.E.Hall, R.A.O'Hair, and R.J.Simpson (2002).
Characterization of an antagonist interleukin-6 dimer by stable isotope labeling, cross-linking, and mass spectrometry.
  J Biol Chem, 277, 46487-46492.  
16232993 H.Mizuguchi, H.Mizuno, K.Yasukawa, T.Ishiguro, K.Fukui, T.Imanaka, and M.Takagi (2001).
Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor.
  J Biosci Bioeng, 91, 299-304.  
11405230 P.Igaz, S.Bösze, S.Tóth, A.Falus, and F.Hudecz (2001).
C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells.
  Biol Chem, 382, 669-676.  
11558598 T.Harada, E.Kurimoto, Y.Moriyama, D.Ejima, T.Sakai, D.Nohara, and K.Kato (2001).
Application of combined reagent solution to the oxidative refolding of recombinant human interleukin 6.
  Chem Pharm Bull (Tokyo), 49, 1128-1131.  
10835339 J.Bravo, and J.K.Heath (2000).
Receptor recognition by gp130 cytokines.
  EMBO J, 19, 2399-2411.  
18726345 J.Feng, Y.Ren, and B.Shen (2000).
Prediction on the binding domain between human interleukin-6 and its receptor.
  Sci China C Life Sci, 43, 409-417.  
10684643 J.M.Matthews, R.S.Norton, A.Hammacher, and R.J.Simpson (2000).
The single mutation Phe173 --> Ala induces a molten globule-like state in murine interleukin-6.
  Biochemistry, 39, 1942-1950.  
  10997905 M.C.Deller, K.R.Hudson, S.Ikemizu, J.Bravo, E.Y.Jones, and J.K.Heath (2000).
Crystal structure and functional dissection of the cytostatic cytokine oncostatin M.
  Structure, 8, 863-874.
PDB code: 1evs
10848977 S.H.Hoischen, P.Vollmer, P.März, S.Ozbek, K.S.Götze, C.Peschel, T.Jostock, T.Geib, J.Müllberg, S.Mechtersheimer, M.Fischer, J.Grötzinger, P.R.Galle, and S.Rose-John (2000).
Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells.
  Eur J Biochem, 267, 3604-3612.  
10494829 J.Grötzinger, T.Kernebeck, K.J.Kallen, and S.Rose-John (1999).
IL-6 type cytokine receptor complexes: hexamer, tetramer or both?
  Biol Chem, 380, 803-813.  
10207005 K.J.Kallen, J.Grötzinger, E.Lelièvre, P.Vollmer, D.Aasland, C.Renné, J.Müllberg, K.H.Myer zum Büschenfelde, H.Gascan, and S.Rose-John (1999).
Receptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6.
  J Biol Chem, 274, 11859-11867.  
  10342555 R.A.Gadient, and P.H.Patterson (1999).
Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury.
  Stem Cells, 17, 127-137.  
9765242 C.Renné, K.J.Kallen, J.Müllberg, T.Jostock, J.Grötzinger, and S.Rose-John (1998).
A new type of cytokine receptor antagonist directly targeting gp130.
  J Biol Chem, 273, 27213-27219.  
9501088 J.Bravo, D.Staunton, J.K.Heath, and E.Y.Jones (1998).
Crystal structure of a cytokine-binding region of gp130.
  EMBO J, 17, 1665-1674.
PDB code: 1bqu
9783743 J.C.Cheetham, D.M.Smith, K.H.Aoki, J.L.Stevenson, T.J.Hoeffel, R.S.Syed, J.Egrie, and T.S.Harvey (1998).
NMR structure of human erythropoietin and a comparison with its receptor bound conformation.
  Nat Struct Biol, 5, 861-866.
PDB code: 1buy
9692957 J.M.Matthews, A.Hammacher, G.J.Howlett, and R.J.Simpson (1998).
Physicochemical characterization of an antagonistic human interleukin-6 dimer.
  Biochemistry, 37, 10671-10680.  
9593715 M.G.Hinds, T.Maurer, J.G.Zhang, N.A.Nicola, and R.S.Norton (1998).
Solution structure of leukemia inhibitory factor.
  J Biol Chem, 273, 13738-13745.
PDB code: 1a7m
9419340 R.J.Duhé, G.A.Evans, R.A.Erwin, R.A.Kirken, G.W.Cox, and W.L.Farrar (1998).
Nitric oxide and thiol redox regulation of Janus kinase activity.
  Proc Natl Acad Sci U S A, 95, 126-131.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.